Ubs Group Ag Daxor Corp Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Daxor Corp stock. As of the latest transaction made, Ubs Group Ag holds 326 shares of DXR stock, worth $3,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares

326

Previous 2,599 87.46%

Holding current value

$3,185

Previous $20,000 90.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$7.0 - $8.5 $15,911 - $19,320	-2,273 Reduced 87.46%	326 $2,000
Q4 2024 Feb 14, 2025	BUY	$7.63 - $9.89 $10,399 - $13,480	1,363 Added 110.28%	2,599 $20,000
Q3 2024 Nov 14, 2024	SELL	$7.86 - $9.7 $22,927 - $28,294	-2,917 Reduced 70.24%	1,236 $10,000
Q2 2024 Aug 13, 2024	BUY	$0.0 - $9.94 $0 - $29,750	2,993 Added 258.02%	4,153 $38,000
Q1 2024 May 13, 2024	BUY	$7.19 - $10.03 $8,340 - $11,634	1,160 New	1,160 $10,000
Q3 2023 Nov 09, 2023	SELL	$9.03 - $10.15 $20,904 - $23,497	-2,315 Reduced 94.53%	134 $1,000
Q2 2023 Aug 11, 2023	BUY	$9.51 - $13.03 $23,289 - $31,910	2,449 New	2,449 $23,000
Q3 2022 Nov 10, 2022	SELL	$12.1 - $14.23 $1,258 - $1,479	-104 Reduced 11.18%	826 $11,000
Q2 2022 Aug 10, 2022	BUY	$10.62 - $13.21 $796 - $990	75 Added 8.77%	930 $12,000
Q1 2022 May 16, 2022	BUY	$10.51 - $11.52 $2,186 - $2,396	208 Added 32.15%	855 $9,000
Q4 2021 Feb 14, 2022	BUY	$10.59 - $11.5 $4,553 - $4,945	430 Added 198.16%	647 $7,000
Q3 2021 Nov 15, 2021	SELL	$8.77 - $12.05 $6,279 - $8,627	-716 Reduced 76.74%	217 $3,000
Q2 2021 Aug 13, 2021	BUY	$8.9 - $14.15 $4,441 - $7,060	499 Added 114.98%	933 $10,000
Q1 2021 May 12, 2021	SELL	$11.02 - $13.86 $9,653 - $12,141	-876 Reduced 66.87%	434 $5,000
Q4 2020 Feb 11, 2021	BUY	$12.15 - $15.77 $6,791 - $8,815	559 Added 74.43%	1,310 $16,000
Q3 2020 Nov 12, 2020	BUY	$14.66 - $23.78 $11,009 - $17,858	751 New	751 $12,000
Q1 2020 May 01, 2020	SELL	$8.6 - $14.25 $9,933 - $16,458	-1,155 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.94 - $9.93 $10,325 - $11,469	1,155 New	1,155 $11,000
Q2 2019 Aug 14, 2019	SELL	$7.5 - $11.61 $10,275 - $15,905	-1,370 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$9.11 - $19.52 $12,480 - $26,742	1,370 New	1,370 $15,000
Q4 2018 Feb 14, 2019	SELL	$4.7 - $9.55 $13,667 - $27,771	-2,908 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.3 - $6.64 $3,822 - $5,902	889 Added 44.03%	2,908 $15,000
Q2 2018 Aug 14, 2018	BUY	$6.12 - $9.82 $10,563 - $16,949	1,726 Added 589.08%	2,019 $13,000
Q1 2018 May 15, 2018	SELL	$3.52 - $13.89 $8,000 - $31,571	-2,273 Reduced 88.58%	293 $3,000
Q4 2017 Feb 14, 2018	SELL	$4.05 - $5.5 $20 - $27	-5 Reduced 0.19%	2,566 $12,000
Q3 2017 Nov 14, 2017	BUY	$5.06 - $6.2 $13,009 - $15,940	2,571	2,571 $13,000

Others Institutions Holding DXR

# of Institutions

Shares Held

96.6K

Call Options Held

Put Options Held

View Full List

About DAXOR CORP

Ticker DXR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 4,041,670
Market Cap $39.5M
Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...

More about DXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account